Bioresorbable soft-tissue sheets
The company describes a surgical thin sheet for soft-tissue applications made from a 70:30 polylactide copolymer.
Source: LinkedIn company description · Retrieved October 13, 2026
Mast Biosurgery focuses on bioresorbable polymer implants and emerging technologies for surgical applications in the biosurgery market.
Its bioresorbable polymer sheets are described as spanning large tissue masses and holding them in place.
Based on the company’s public LinkedIn information, supplied through RevenueBase.
The company describes a surgical thin sheet for soft-tissue applications made from a 70:30 polylactide copolymer.
Source: LinkedIn company description · Retrieved October 13, 2026
Supported appearances on published RevenueBase lists, including available memberships beyond displayed rankings.
Positions describe ordering within each source list. See how lists are built ↗
Embeddable award for your website
RevenueBase prepared this profile from the company’s public LinkedIn information and RevenueBase company data. These source records were retrieved on October 13, 2026. AI helped summarize these sources, with a separate automated check against the source text completed on November 4, 2026. Directory positions use company-contact counts from separate saved list snapshots dated September 15, 2026, September 18, 2026, September 29, 2026 and October 7, 2026. How the company lists are built.
Share a correction, your relationship to the company, and supporting sources. Requests are reviewed before changes are published.
Explore more companies by name, headquarters and business focus.